Neuberger Berman Group
CHRS icon

Neuberger Berman Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Neuberger Berman Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$16.4K Buy
22,371
+4,341
+24% +$3.18K ﹤0.01% 2029
2025
Q1 		$14.6K Buy
+18,030
New +$14.6K ﹤0.01% 1945